Fulcrum Capital LLC Abbott Laboratories Transaction History

Fulcrum Capital LLC

  • $451 Million
  • Q3 2024

A detailed history of Fulcrum Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Fulcrum Capital LLC holds 43,619 shares of ABT stock, worth $5.03 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
43,619
Previous 42,946 1.57%
Holding current value
$5.03 Million
Previous $4.46 Million 11.45%
% of portfolio
1.1%
Previous 1.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
BUY
$100.07 - $118.13 $67,347 - $79,501
673 Added 1.57%
43,619 $4.97 Million
Q2 2024

Jul 22, 2024
BUY
$100.73 - $112.44 $156,030 - $174,169
1,549 Added 3.74%
42,946 $4.46 Million
Q1 2024

Apr 17, 2024
BUY
$109.52 - $120.96 $108,972 - $120,355
995 Added 2.46%
41,397 $4.71 Million
Q4 2023

Jan 10, 2024
BUY
$90.19 - $110.4 $230,615 - $282,292
2,557 Added 6.76%
40,402 $4.45 Million
Q3 2023

Oct 13, 2023
SELL
$95.53 - $114.62 $1.59 Million - $1.91 Million
-16,677 Reduced 30.59%
37,845 $3.67 Million
Q2 2023

Jul 27, 2023
SELL
$100.78 - $112.29 $233,305 - $259,951
-2,315 Reduced 4.07%
54,522 $5.94 Million
Q1 2023

May 10, 2023
BUY
$96.86 - $114.01 $305,302 - $359,359
3,152 Added 5.87%
56,837 $5.76 Million
Q4 2022

Jan 24, 2023
BUY
$95.06 - $111.52 $402,674 - $472,398
4,236 Added 8.57%
53,685 $0
Q3 2022

Oct 17, 2022
SELL
$96.76 - $112.03 $12,095 - $14,003
-125 Reduced 0.25%
49,449 $4.79 Million
Q2 2022

Aug 03, 2022
SELL
$102.07 - $123.37 $2.26 Million - $2.73 Million
-22,143 Reduced 30.88%
49,574 $5.39 Million
Q1 2022

May 05, 2022
BUY
$114.02 - $139.04 $181,063 - $220,795
1,588 Added 2.26%
71,717 $8.49 Million
Q4 2021

Jan 25, 2022
BUY
$115.53 - $141.46 $381,249 - $466,818
3,300 Added 4.94%
70,129 $9.87 Million
Q3 2021

Oct 21, 2021
BUY
$116.66 - $129.06 $293,983 - $325,231
2,520 Added 3.92%
66,829 $7.9 Million
Q2 2021

Jul 30, 2021
BUY
$105.79 - $124.53 $463,889 - $546,064
4,385 Added 7.32%
64,309 $7.46 Million
Q1 2021

Apr 12, 2021
SELL
$108.84 - $128.23 $87,616 - $103,225
-805 Reduced 1.33%
59,924 $7.18 Million
Q4 2020

Feb 09, 2021
BUY
$105.0 - $114.42 $57,330 - $62,473
546 Added 0.91%
60,729 $6.65 Million
Q3 2020

Oct 21, 2020
SELL
$91.64 - $111.29 $735,411 - $893,102
-8,025 Reduced 11.77%
60,183 $6.55 Million
Q2 2020

Jul 27, 2020
SELL
$76.57 - $98.0 $314,932 - $403,074
-4,113 Reduced 5.69%
68,208 $6.24 Million
Q1 2020

May 01, 2020
SELL
$62.82 - $91.86 $102,710 - $150,191
-1,635 Reduced 2.21%
72,321 $5.71 Million
Q4 2019

Feb 03, 2020
BUY
$78.51 - $87.4 $160,709 - $178,907
2,047 Added 2.85%
73,956 $6.42 Million
Q3 2019

Oct 31, 2019
BUY
$81.84 - $88.74 $217,530 - $235,870
2,658 Added 3.84%
71,909 $12.5 Million
Q2 2019

Jul 29, 2019
BUY
$72.88 - $85.0 $278,766 - $325,125
3,825 Added 5.85%
69,251 $5.82 Million
Q1 2019

May 08, 2019
BUY
$66.22 - $80.06 $167,867 - $202,952
2,535 Added 4.03%
65,426 $5.23 Million
Q4 2018

Feb 12, 2019
SELL
$65.56 - $74.27 $91,193 - $103,309
-1,391 Reduced 2.16%
62,891 $4.55 Million
Q3 2018

Nov 06, 2018
SELL
$60.81 - $73.36 $7,662 - $9,243
-126 Reduced 0.2%
64,282 $4.72 Million
Q2 2018

Aug 03, 2018
SELL
$57.57 - $63.54 $28,727 - $31,706
-499 Reduced 0.77%
64,408 $3.93 Million
Q1 2018

May 09, 2018
SELL
$56.27 - $63.62 $94,308 - $106,627
-1,676 Reduced 2.52%
64,907 $3.89 Million
Q4 2017

Jan 30, 2018
BUY
$53.68 - $57.47 $3.57 Million - $3.83 Million
66,583
66,583 $3.8 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Fulcrum Capital LLC Portfolio

Follow Fulcrum Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email